{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:31:35Z","timestamp":1761895895598},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,7,23]],"date-time":"2014-07-23T00:00:00Z","timestamp":1406073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,7,23]],"date-time":"2014-07-23T00:00:00Z","timestamp":1406073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s00277-014-2165-2","type":"journal-article","created":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T02:16:40Z","timestamp":1405995400000},"page":"107-115","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The treatment outcome of multiple myeloma patients ineligible for hematopoietic transplantation\u2014a single institutional experience in Taiwan"],"prefix":"10.1007","volume":"94","author":[{"given":"Tzu-Chuan","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping-Ying","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Shen","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsu-Yi","family":"Chao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woei-Yau","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeu-Chin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Liang","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,23]]},"reference":[{"issue":"7","key":"2165_CR1","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1056\/NEJM199402173300709","volume":"330","author":"R Alexanian","year":"1994","unstructured":"Alexanian R, Dimopoulos M (1994) The treatment of multiple myeloma. N Engl J Med 330(7):484\u2013489","journal-title":"N Engl J Med"},{"issue":"11","key":"2165_CR2","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1056\/NEJMra1011442","volume":"364","author":"A Palumbo","year":"2011","unstructured":"Palumbo A, Anderson K (2011) Multiple myeloma. N Engl J Med 364(11):1046\u20131060","journal-title":"N Engl J Med"},{"issue":"1","key":"2165_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4065\/78.1.21","volume":"78","author":"RA Kyle","year":"2003","unstructured":"Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, Fonseca R, Rajkumar SV, Offord JR, Larson DR, Plevak ME, Therneau TM, Greipp PR (2003) Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 78(1):21\u201333","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"2165_CR4","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/cncr.22850","volume":"110","author":"SY Huang","year":"2007","unstructured":"Huang SY, Yao M, Tang JL, Lee WC, Tsay W, Cheng AL, Wang CH, Chen YC, Shen MC, Tien HF (2007) Epidemiology of multiple myeloma in Taiwan: increasing incidence for the past 25\u00a0years and higher prevalence of extramedullary myeloma in patients younger than 55\u00a0years. Cancer 110(4):896\u2013905","journal-title":"Cancer"},{"issue":"1","key":"2165_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1182\/blood-2003-04-1045","volume":"103","author":"B Barlogie","year":"2004","unstructured":"Barlogie B, Shaughnessy J, Tricot G, Jacobson J, Zangari M, Anaissie E, Walker R, Crowley J (2004) Treatment of multiple myeloma. Blood 103(1):20\u201332","journal-title":"Blood"},{"issue":"15","key":"2165_CR6","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1200\/JCO.2006.09.0100","volume":"25","author":"SY Kristinsson","year":"2007","unstructured":"Kristinsson SY, Landgren O, Dickman PW, Derolf AR, Bj\u00f6rkholm M (2007) Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003. J Clin Oncol 25(15):1993\u20131999","journal-title":"J Clin Oncol"},{"issue":"3","key":"2165_CR7","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","volume":"36","author":"BG Durie","year":"1975","unstructured":"Durie BG, Salmon SE (1975) A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 36(3):842\u2013854","journal-title":"Cancer"},{"issue":"15","key":"2165_CR8","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","volume":"23","author":"PR Greipp","year":"2005","unstructured":"Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Blad\u00e9 J, Boccadoro M, Child JA, Avet-Loiseau H, Kyle RA, Lahuerta JJ, Ludwig H, Morgan G, Powles R, Shimizu K, Shustik C, Sonneveld P, Tosi P, Turesson I, Westin J (2005) International staging system for multiple myeloma. J Clin Oncol 23(15):3412\u20133420","journal-title":"J Clin Oncol"},{"issue":"6","key":"2165_CR9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130(6):461\u2013470","journal-title":"Ann Intern Med"},{"issue":"9","key":"2165_CR10","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","volume":"20","author":"BG Durie","year":"2006","unstructured":"Durie BG, Harousseau JL, Miguel JS, Blad\u00e9 J, Barlogie B, Anderson K, Gertz M, Dimopoulos M, Westin J, Sonneveld P, Ludwig H, Gahrton G, Beksac M, Crowley J, Belch A, Boccadaro M, Cavo M, Turesson I, Joshua D, Vesole D, Kyle R, Alexanian R, Tricot G, Attal M, Merlini G, Powles R, Richardson P, Shimizu K, Tosi P, Morgan G, Rajkumar SV, International Myeloma Working Group (2006) International uniform response criteria for multiple myeloma. Leukemia 20(9):1467\u20131473","journal-title":"Leukemia"},{"issue":"2","key":"2165_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.arcmed.2003.09.013","volume":"35","author":"GJ Ruiz-Arg\u00fcelles","year":"2004","unstructured":"Ruiz-Arg\u00fcelles GJ, G\u00f3mez-Rangel JD, Ruiz-Delgado GJ, Aguilar-Romero L (2004) Multiple myeloma in Mexico: a 20-year experience at a single institution. Arch Med Res 35(2):163\u2013167","journal-title":"Arch Med Res"},{"issue":"1","key":"2165_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s12185-010-0617-6","volume":"92","author":"JH Lee","year":"2010","unstructured":"Lee JH, Lee DS, Lee JJ, Chang YH, Jin JY, Jo DY, Bang SM, Kim HJ, Kim JS, Kim K, Eom HS, Min CK, Yoon SS, Kim SH, Suh C, Cho KS, Korean Multiple Myeloma Working Party (2010) Multiple myeloma in Korea: past, present, and future perspectives. Experience of the Korean Multiple Myeloma Working Party. Int J Hematol 92(1):52\u201357","journal-title":"Int J Hematol"},{"issue":"3","key":"2165_CR13","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1046\/j.1365-2141.2003.04456.x","volume":"122","author":"JL Jacobson","year":"2003","unstructured":"Jacobson JL, Hussein MA, Barlogie B, Durie BG, Crowley JJ, Southwest Oncology Group (2003) A new staging system for multiple myeloma patients based on the Southwest Oncology Group (SWOG) experience. Br J Haematol 122(3):441\u2013450","journal-title":"Br J Haematol"},{"issue":"22","key":"2165_CR14","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1200\/JCO.2008.21.0948","volume":"27","author":"C Hulin","year":"2009","unstructured":"Hulin C, Facon T, Rodon P, Pegourie B, Benboubker L, Doyen C, Dib M, Guillerm G, Salles B, Eschard JP, Lenain P, Casassus P, Aza\u00efs I, Decaux O, Garderet L, Mathiot C, Fontan J, Lafon I, Virion JM, Moreau P (2009) Efficacy of melphalan and prednisone plus thalidomide in patients older than 75\u00a0years with newly diagnosed multiple myeloma: IFM 01\/01 trial. J Clin Oncol 27(22):3664\u20133670","journal-title":"J Clin Oncol"},{"issue":"19","key":"2165_CR15","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1200\/JCO.2009.26.1610","volume":"28","author":"P Wijermans","year":"2010","unstructured":"Wijermans P, Schaafsma M, Termorshuizen F, Ammerlaan R, Wittebol S, Sinnige H, Zweegman S, van Marwijk Kooy M, van der Griend R, Lokhorst H, Sonneveld P, Dutch-Belgium Cooperative Group HOVON (2010) Phase III study of the value of thalidomide added to melphalan plus prednisone in elderly patients with newly diagnosed multiple myeloma: the HOVON 49 Study. J Clin Oncol 28(19):3160\u20133166","journal-title":"J Clin Oncol"},{"issue":"3","key":"2165_CR16","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s12185-013-1294-z","volume":"97","author":"R Watanabe","year":"2013","unstructured":"Watanabe R, Tokuhira M, Kizaki M (2013) Current approaches for the treatment of multiple myeloma. Int J Hematol 97(3):333\u2013344","journal-title":"Int J Hematol"},{"issue":"5","key":"2165_CR17","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1182\/blood-2011-03-341669","volume":"118","author":"PM Fayers","year":"2011","unstructured":"Fayers PM, Palumbo A, Hulin C, Waage A, Wijermans P, Beksa\u00e7 M, Bringhen S, Mary JY, Gimsing P, Termorshuizen F, Haznedar R, Caravita T, Moreau P, Turesson I, Musto P, Benboubker L, Schaafsma M, Sonneveld P, Facon T, Nordic Myeloma Study Group, Italian Multiple Myeloma Network, Turkish Myeloma Study Group, Hemato-Oncologie voor Volwassenen Nederland, Intergroupe Francophone du My\u00e9lome, European Myeloma Network (2011) Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials. Blood 118(5):1239\u20131247","journal-title":"Blood"},{"issue":"3","key":"2165_CR18","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1200\/JCO.2005.03.0221","volume":"24","author":"SV Rajkumar","year":"2006","unstructured":"Rajkumar SV, Blood E, Vesole D, Fonseca R, Greipp PR, Eastern Cooperative Oncology Group (2006) Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology Group. J Clin Oncol 24(3):431\u2013436","journal-title":"J Clin Oncol"},{"issue":"13","key":"2165_CR19","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1200\/JCO.2007.14.1853","volume":"26","author":"SV Rajkumar","year":"2008","unstructured":"Rajkumar SV, Rosi\u00f1ol L, Hussein M, Catalano J, Jedrzejczak W, Lucy L, Olesnyckyj M, Yu Z, Knight R, Zeldis JB, Blad\u00e9 J (2008) Multicenter, randomized, double-blind, placebo-controlled study of thalidomide plus dexamethasone compared with dexamethasone as initial therapy for newly diagnosed multiple myeloma. J Clin Oncol 26(13):2171\u20132177","journal-title":"J Clin Oncol"},{"issue":"15","key":"2165_CR20","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1182\/blood-2008-07-169565","volume":"113","author":"H Ludwig","year":"2009","unstructured":"Ludwig H, Hajek R, T\u00f3thov\u00e1 E, Drach J, Adam Z, Labar B, Egyed M, Spicka I, Gisslinger H, Greil R, Kuhn I, Zojer N, Hinke A (2009) Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma. Blood 113(15):3435\u20133442","journal-title":"Blood"},{"issue":"11","key":"2165_CR21","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1007\/s00277-012-1506-2","volume":"91","author":"SY Wu","year":"2012","unstructured":"Wu SY, Yeh YM, Chen YP, Su WC, Chen TY (2012) Low incidence of thromboembolism in relapsed\/refractory myeloma patients treated with thalidomide without thromboprophylaxis in Taiwan. Ann Hematol 91(11):1773\u20131778","journal-title":"Ann Hematol"},{"issue":"3","key":"2165_CR22","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1053\/j.seminhematol.2009.03.006","volume":"46","author":"M Nucci","year":"2009","unstructured":"Nucci M, Anaissie E (2009) Infections in patients with multiple myeloma. Semin Hematol 46(3):277\u2013288","journal-title":"Semin Hematol"},{"issue":"8","key":"2165_CR23","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1086\/605664","volume":"49","author":"M Nucci","year":"2009","unstructured":"Nucci M, Anaissie E (2009) Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents. Clin Infect Dis 49(8):1211\u20131225","journal-title":"Clin Infect Dis"},{"issue":"24","key":"2165_CR24","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1056\/NEJMoa043445","volume":"352","author":"PG Richardson","year":"2005","unstructured":"Richardson PG, Sonneveld P, Schuster MW, Irwin D, Stadtmauer EA, Facon T, Harousseau JL, Ben-Yehuda D, Lonial S, Goldschmidt H, Reece D, San-Miguel JF, Blad\u00e9 J, Boccadoro M, Cavenagh J, Dalton WS, Boral AL, Esseltine DL, Porter JB, Schenkein D, Anderson KC, Assessment of Proteasome Inhibition for Extending Remissions (APEX) Investigators (2005) Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. N Engl J Med 352(24):2487\u20132498","journal-title":"N Engl J Med"},{"issue":"1","key":"2165_CR25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1365-2141.2012.09233.x","volume":"159","author":"J Minarik","year":"2012","unstructured":"Minarik J, Pika T, Bacovsky J, Langova K, Scudla V (2012) Low-dose acyclovir prophylaxis for bortezomib-induced herpes zoster in multiple myeloma patients. Br J Haematol 159(1):111\u2013113","journal-title":"Br J Haematol"},{"issue":"7","key":"2165_CR26","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1093\/jjco\/hyr063","volume":"41","author":"T Aoki","year":"2011","unstructured":"Aoki T, Nishiyama T, Imahashi N, Kitamura K (2011) Efficacy of continuous, daily, oral, ultra-low-dose 200\u00a0mg acyclovir to prevent herpes zoster events among bortezomib-treated patients: a report from retrospective study. Jpn J Clin Oncol 41(7):876\u2013881","journal-title":"Jpn J Clin Oncol"},{"key":"2165_CR27","doi-asserted-by":"crossref","unstructured":"Blimark C, Mellqvist UH, Landgren O, Bj\u00f6rkholm M, Hultcrantz ML, Kjellander C, Turesson I, Holmberg E, Kristinsson SY (2012) Multiple myeloma and infections: a population-based study based on 9,610 multiple myeloma patients. ASH; Abstract 945","DOI":"10.1182\/blood.V120.21.945.945"},{"issue":"15","key":"2165_CR28","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1200\/JCO.2009.25.4250","volume":"28","author":"AA Chanan-Khan","year":"2010","unstructured":"Chanan-Khan AA, Giralt S (2010) Importance of achieving a complete response in multiple myeloma, and the impact of novel agents. J Clin Oncol 28(15):2612\u20132624","journal-title":"J Clin Oncol"},{"key":"2165_CR29","doi-asserted-by":"crossref","unstructured":"Reference: Larocca A, Bringhen S, Evangelista A, Offidani M, Ballanti S, Zaccaria A, Pescosta N, Montefusco V, Rosa LD, Carella AM, Baldini L, Aglietta M, Vincelli ID, Marasca R, Pezzati S, Tosi P, Cocito F, Grasso M, Fioritoni G, Pavone V, Musto P, Grammatico S, Omed\u00e8 P, Gay F, Ciccone G, Mario Boccadoro M, Palumbo A (2013) A simple score, based on geriatric assessment, improves prediction of survival, and risk of serious adverse events in elderly newly diagnosed multiple myeloma patients. ASH; Abstract 687","DOI":"10.1182\/blood.V122.21.687.687"},{"issue":"6","key":"2165_CR30","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1200\/JCO.2013.48.7934","volume":"32","author":"A Palumbo","year":"2014","unstructured":"Palumbo A, Rajkumar SV, San Miguel JF, Larocca A, Niesvizky R, Morgan G, Landgren O, Hajek R, Einsele H, Anderson KC, Dimopoulos MA, Richardson PG, Cavo M, Spencer A, Stewart AK, Shimizu K, Lonial S, Sonneveld P, Durie BG, Moreau P, Orlowski RZ (2014) International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation. J Clin Oncol 32(6):587\u2013600","journal-title":"J Clin Oncol"},{"issue":"10","key":"2165_CR31","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1038\/leu.2013.185","volume":"27","author":"P Sonneveld","year":"2013","unstructured":"Sonneveld P, Verelst SG, Lewis P, Gray-Schopfer V, Hutchings A, Nixon A, Petrucci MT (2013) Review of health-related quality of life data in multiple myeloma patients treated with novel agents. Leukemia 27(10):1959\u20131969","journal-title":"Leukemia"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-014-2165-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-014-2165-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-014-2165-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-014-2165-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T01:32:53Z","timestamp":1659058373000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-014-2165-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,23]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["2165"],"URL":"https:\/\/doi.org\/10.1007\/s00277-014-2165-2","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,23]]},"assertion":[{"value":"3 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}